Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lüftner

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Anticancer Research|July 26, 2007
Clinical value of bisphosphonates in cancer therapyD Lüftner, P Henschke, K Possinger
The International Journal of Biological Markers|July 10, 1999
c-erbB-2 in serum of patients receiving fractionated paclitaxel chemotherapyD Lüftner, S Schnabel, K Possinger
Journal of Perinatal Medicine|January 1, 1994
Efficacy and safety of a 2-tier prostaglandin labor induction scheduleK T Schneider, D Lüftner, W Rath
European Journal of Haematology|June 1, 2002
Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphomaI Genvresse, D Lüftner, E Späth-Schwalbe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 22, 2014
A survey of treatment approaches of malignant ascites in Germany and AustriaC F Jehn, S Küpferling, G Oskay-Özcelik, et al.
The International Journal of Biological Markers|October 27, 2004
ADVIA Centaur HER-2/neu shows value in monitoring patients with metastatic breast cancerD Lüftner, C Cheli, K Mickelson, et al.
Anticancer Research|December 13, 2005
Perspectives of immunotherapy in metastatic breast cancerD Lüftner, D Pollmann, S Schildhauer, et al.
Zentralblatt Fur Gynakologie|January 1, 1994
[Labor induction with prostaglandin in post-cesarean section status]K T Schneider, D Lüftner, W Rath, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2014
Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancerC F Jehn, L Böning, H Kröning, et al.
Anticancer Research|March 14, 2007
Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer: first results of a phase III studyC F Jehn, T Boulikas, A Kourvetaris, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Anticancer Research|July 26, 2007
Clinical value of bisphosphonates in cancer therapyD Lüftner, P Henschke, K Possinger
The International Journal of Biological Markers|July 10, 1999
c-erbB-2 in serum of patients receiving fractionated paclitaxel chemotherapyD Lüftner, S Schnabel, K Possinger
Journal of Perinatal Medicine|January 1, 1994
Efficacy and safety of a 2-tier prostaglandin labor induction scheduleK T Schneider, D Lüftner, W Rath
European Journal of Haematology|June 1, 2002
Prevalence and clinical significance of anticardiolipin and anti-beta2-glycoprotein-I antibodies in patients with non-Hodgkin's lymphomaI Genvresse, D Lüftner, E Späth-Schwalbe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 22, 2014
A survey of treatment approaches of malignant ascites in Germany and AustriaC F Jehn, S Küpferling, G Oskay-Özcelik, et al.
The International Journal of Biological Markers|October 27, 2004
ADVIA Centaur HER-2/neu shows value in monitoring patients with metastatic breast cancerD Lüftner, C Cheli, K Mickelson, et al.
Anticancer Research|December 13, 2005
Perspectives of immunotherapy in metastatic breast cancerD Lüftner, D Pollmann, S Schildhauer, et al.
Zentralblatt Fur Gynakologie|January 1, 1994
[Labor induction with prostaglandin in post-cesarean section status]K T Schneider, D Lüftner, W Rath, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2014
Influence of comorbidity, age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancerC F Jehn, L Böning, H Kröning, et al.
Anticancer Research|March 14, 2007
Pharmacokinetics of liposomal cisplatin (lipoplatin) in combination with 5-FU in patients with advanced head and neck cancer: first results of a phase III studyC F Jehn, T Boulikas, A Kourvetaris, et al.
Pageof 5